3-Deoxysappanchalcone Inhibited High Mobility Group Box Protein 1-Mediated Severe Inflammatory Responses
<b>Background/Objectives:</b> Phytochemicals are increasingly recognized for their therapeutic potential in treating various diseases, including vascular disorders. High mobility group box 1 (HMGB1), a key mediator of late-stage sepsis, triggers the release of proinflammatory cytokines,...
Saved in:
| Main Authors: | Jinhee Lee, Gyuri Han, Jong-Sup Bae |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/5/731 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High-mobility group box 1 in acute kidney injury
by: Xuan Li, et al.
Published: (2025-07-01) -
Crosstalk between miRNAs, high mobility group box-1 and complement system in epilepsy: relevance of response to valproic acid
by: Dalia Kamal Mostafa, et al.
Published: (2025-08-01) -
The Association Between Serum HMGB2 Levels and Abdominal Aortic Aneurysm in Males: Insights Into the HMGB2–TREM Pathway
by: Liting Pan, et al.
Published: (2025-07-01) -
The effects of the combination of resistance exercise and heat stress on cell production and plasma levels of cytokines
by: Maryam Zilaei Bouri, et al.
Published: (2024-01-01) -
Ginsenoside Rb1 inhibits proliferation and promotes apoptosis by regulating HMGB1 in uterine fibroid cells
by: Jianqiang Zhang, et al.
Published: (2019-12-01)